Abstract
The effect of a domain peptide DPCPVTc from the central region of the RYR2 on ryanodine receptors from rat heart has been examined in planar lipid bilayers. At a zero holding potential and at 8 mmol L−1 luminal Ca2+ concentration, DPCPVTc induced concentrationdependent activation of the ryanodine receptor that led up to 20-fold increase of PO at saturating DPCPVTc concentrations. DPCPVTc prolonged RyR2 openings and increased RyR2 opening frequency. At all peptide concentrations the channels displayed large variability in open probability, open time and frequency of openings. With increasing peptide concentration, the fraction of high open probability records increased together with their open time. The closed times of neither low- nor high-open probability records depended on peptide concentration. The concentration dependence of all gating parameters had EC50 of 20 μmol L−1 and a Hill slope of 2. Comparison of the effects of DPCPVTc with the effects of ATP and cytosolic Ca2+ suggests that activation does not involve luminal feed-through and is not caused by modulation of the cytosolic activation A-site. The data suggest that although “domain unzipping” by DPCPVTc occurs in both modes of RyR activity, it affects RyR gating only when the channel resides in the H-mode of activity.
Similar content being viewed by others
References
Yano M., Yamamoto T., Ikeda Y., Matsuzaki M., Mechanisms of Disease: ryanodine receptor defects in heart failure and fatal arrhythmia, Nat. Clin. Pract. Cardiovasc. Med., 2006, 3, 43–52
Bhat M.B., Zhao J., Takeshima H., Ma J., Functional calcium release channel formed by the carboxylterminal portion of ryanodine receptor, Biophys. J. 1997, 73, 1329–1336.
Durham W.J., Wehrens X.H., Sood S., Hamilton S.L., Diseases associated with altered ryanodine receptor activity, Sub-cellular Biochem., 2007, 45, 273–321
Lanner J.T., Ryanodine receptor physiology and its role in disease, Adv. Exp. Med. Biol. 2012, 740, 217–234
Ikemoto N., Yamamoto T., Regulation of calcium release by interdomain interaction within ryanodine receptors, Front. Biosci., 2002, 7, d671–683
Laver D.R., Honen B.N., Lamb G.D., Ikemoto N., A domain peptide of the cardiac ryanodine receptor regulates channel sensitivity to luminal Ca2+ via cytoplasmic Ca2+ sites, Eur. Biophys. J., 2008, 37, 455–467
Gaburjakova J., Gaburjakova M., Comparison of the effects exerted by luminal Ca2+ on the sensitivity of the cardiac ryanodine receptor to caffeine and cytosolic Ca2+, J. Membr. Biol., 2006, 212, 17–28
Rousseau E., Smith J.S., Henderson J.S., Meissner G., Single channel and 45 Ca2+ flux measurements of the cardiac sarcoplasmic reticulum calcium channel, Biophys. J., 1986, 50, 1009–1014
Tencerova B., Zahradnikova A., Gaburjakova J., Gaburjakova M., Luminal Ca2+ controls activation of the cardiac ryanodine receptor by ATP, J. Gen. Physiol., 2012, 140, 93–108
Zahradnikova A., Zahradnik I., Description of modal gating of the cardiac calcium release channel in planar lipid membranes, Biophys. J., 1995, 69, 1780–1788
Tiso N., Stephan D.A., Nava A., Bagattin A., Devaney J.M., Stanchi F., et al., Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2), Hum. Mol. Genet. 2001, 10, 189–194
Tester D.J., Kopplin L.J., Will M.L., Ackerman M.J., Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing, Heart Rhythm., 2005, 2, 1099–1105
Bagattin A., Veronese C., Bauce B., Wuyts W., Settimo L., Nava A., et al., Denaturing HPLC-based approach for detecting RYR2 mutations involved in malignant arrhythmias, Clin. Chem., 2004, 50, 1148–1155
Medeiros-Domingo A., Bhuiyan Z.A., Tester D.J., Hofman N., Bikker H., Van Tintelen J.P., et al., The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exerciseinduced long QT syndrome: a comprehensive open reading frame mutational analysis, J. Am. Coll. Cardiol., 2009, 54, 2065–2074
Bauce B., Rampazzo A., Basso C., Bagattin A., Daliento L., Tiso N., et al., Screening for ryanodine receptor type 2 mutations in families with effortinduced polymorphic ventricular arrhythmias and sudden death: early diagnosis of asymptomatic carriers, J. Am. Coll. Cardiol., 2002, 40, 341–349
Postma A.V., Denjoy I., Kamblock J., Alders M., Lupoglazoff J.M., Vaksmann G., et al., Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients, J. Med. Genet. 2005, 42, 863–870
Aizawa Y., Ueda K., Komura S., Washizuka T., Chinushi M., Inagaki N., et al., A novel mutation in FKBP12.6 binding region of the human cardiac ryanodine receptor gene (R2401H) in a Japanese patient with catecholaminergic polymorphic ventricular tachycardia, Int. J. Cardiol. 2005, 99, 343–345
Creighton W., Virmani R., Kutys R., Burke A., Identification of novel missense mutations of cardiac ryanodine receptor gene in exerciseinduced sudden death at autopsy, J. Mol. Diagnostics, 2006, 8, 62–67
Choi G., Kopplin L.J., Tester D.J., Will M.L., Haglund C.M., Ackerman M.J., Spectrum and frequency of cardiac channel defects in swimmingtriggered arrhythmia syndromes, Circulation, 2004, 110, 2119–2124
Beckmann B.M., Wilde A.A., Kaab S., Dual inheritance of sudden death from cardiovascular causes, N. Engl. J. Med., 2008, 358, 2077–2078
Ikemoto N., Yamamoto T., Postulated role of interdomain interaction within the ryanodine receptor in Ca(2+) channel regulation, Trends Cardiovasc. Med., 2000, 10, 310–316
Yamamoto T., El-Hayek R., Ikemoto N., Postulated role of interdomain interaction within the ryanodine receptor in Ca(2+) channel regulation, J. Biol. Chem., 2000, 275, 11618–11625
Yamamoto T., Ikemoto N., Peptide probe study of the critical regulatory domain of the cardiac ryanodine receptor, Biochem. Biophys. Res. Commun. 2002, 291, 1102–1108.
Kobayashi S., Yamamoto T., Parness J., Ikemoto N., Antibody probe study of Ca2+ channel regulation by interdomain interaction within the ryanodine receptor, Biochem. J., 2004, 380, 561–569
Yamamoto T., Yano M., Xu X., Uchinoumi H., Tateishi H., Mochizuki M., et al., Identification of target domains of the cardiac ryanodine receptor to correct channel disorder in failing hearts, Circulation, 2008, 117, 762–772
Suetomi T., Yano M., Uchinoumi H., Fukuda M., Hino A., Ono M., et al., Mutation-linked defective interdomain interactions within ryanodine receptor cause aberrant Ca2+ release leading to catecholaminergic polymorphic ventricular tachycardia, Circulation, 2011, 124, 682–694
Zahradnikova A., Zahradnik I., Modification of cardiac Ca2+ release channel gating by DIDS, Pflugers Arch., 1993, 425, 555–557
Zahradnikova A., Zahradnik I., Construction of calcium release sites in cardiac myocytes, Front Physiol., 2012, 3, 322
Zahradnikova A., Valent I., Zahradnik I., Frequency and release flux of calcium sparks in rat cardiac myocytes: a relation to RYR gating, J. Gen. Physiol., 2010, 136, 101–116
Zahradnik I., Gyorke S., Zahradnikova A., Calcium activation of ryanodine receptor channels—reconciling RyR gating models with tetrameric channel structure, J. Gen. Physiol., 2005, 126, 515–527
Janicek R., Zahradnikova A.,Jr., Polakova E., Pavelkova J., Zahradnik I., Zahradnikova A., Calcium spike variability in cardiac myocytes results from activation of small cohorts of ryanodine receptor 2 channels, J. Physiol., 2012, 590, 5091–5106
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Faltinová, A., Zahradníková, A. Modification of cardiac RYR2 gating by a peptide from the central domain of the RYR2. cent.eur.j.biol. 8, 1164–1171 (2013). https://doi.org/10.2478/s11535-013-0241-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s11535-013-0241-6